Newton Colmore is working with a drug discovery company in Cambridge, and we are assisting them with their search for a principal scientist to join their growing bioinformatics team.

In this exciting new role, you will be developing complex bioinformatic algorithms, databases and tools that will have a direct effect on the company’s future research and development programmes. You will be working alongside data engineers and data analysts as a part of a multidisciplinary team, reporting directly to the director of bioinformatics.

As part of the bioinformatics team, you will be working on your own projects, and taking charge of them from start to finish. The first project you will be undertaking is of vital importance to the client with high visibility across the company and within the field of proteomics.

You will be responsible for driving the development of databases that help the company understand the best targets and approaches to deliver novel therapies to patients. This will involve utilising machine learning algorithms and techniques across a spectrum of fields.

This is a great opportunity to join a company and make a real difference with your knowledge and experience, leading bioinformatics projects from day one.

We are looking for scientists who have developed code in Python coupled with experience in the bioinformatics/omics field. This will be complemented by experience with Rosetta and sequence analysis, ideally within proteomics.

This company are working on products that will aim to save and improve people’s lives and they need scientists and engineers who share that passion.

The client is offering competitive salaries tailored to your expectations as well as a comprehensive benefits package that includes share options and discretionary bonuses.

For more information, make an application now and a member of our team at Newton Colmore will be in touch with more detail.

Newton Colmore is a highly specialist recruitment consultancy that offers tailored solutions to the biotech, drug discovery, and medical devices markets across the US and the UK.